The global comparator drug sourcing market, valued at USD 1.25 billion in 2024, is projected to grow at a CAGR of 5.9% from 2025 to 2034. This steady growth is being driven by the rising demand for biosimilars, the expansion of global clinical trial networks, and increasing regulatory emphasis on comparative efficacy studies. As pharmaceutical companies seek to demonstrate the value of their...